# Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma

> **NCT01735409** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 69 (estimated)

## Conditions studied

- Nasopharyngeal Neoplasms

## Interventions

- **DRUG:** ABX + DDP
- **DRUG:** ABX + DDP
- **DRUG:** ABX + DDP

## Key facts

- **NCT ID:** NCT01735409
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2014-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01735409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01735409, "Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01735409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*